VCU Medical Center North Hospital
Richmond, Virginia 23298-5028
1 studies enrolling now · 2 studies all time
What they study most
Alpha1-Antitrypsin Deficiency, Hepatocellular Carcinoma
Studies at this site
- Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein — Recruiting now
- A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis — Running, not enrolling